Sri Kosaraju
About Sri Kosaraju
Sri Kosaraju is the President and CEO of a leading company, serves on the boards of Nevro and 10x Genomics, and has a strong background in healthcare and technology finance.
Sri Kosaraju: President and CEO
Sri Kosaraju serves as the President and Chief Executive Officer, bringing extensive experience and leadership to his role. His strategic vision and expertise play a critical role in guiding the company towards its objectives and fostering growth. Kosaraju’s role as CEO allows him to influence the company’s direction profoundly, focusing on innovation and operational excellence.
Board Memberships: Nevro and 10x Genomics
Sri Kosaraju is an active member of the Board of Directors for Nevro and 10x Genomics. In addition to his board responsibilities, he chairs the Audit Committee for both companies. His roles on these boards involve governance, oversight, and ensuring the financial integrity of these organizations, crucial for their ongoing compliance and strategic planning.
Participation in White House Summit on Biotechnology and Biomanufacturing
Sri Kosaraju participated in the White House Summit on Biotechnology and Biomanufacturing, demonstrating his involvement and commitment to advancing the biotechnology sector. His participation in such a significant event underscores his dedication to staying at the forefront of industry developments and contributing to national discussions on biotechnology and biomanufacturing.
Educational Background: Massachusetts Institute of Technology
Sri Kosaraju holds a Bachelor of Science degree from the Massachusetts Institute of Technology (MIT). This rigorous academic background provided him with a solid foundation in technical knowledge and analytical skills, which are key assets in his professional roles. MIT’s esteemed reputation further highlights Kosaraju’s strong educational credentials.
Previous Role at Penumbra
Before his current role, Sri Kosaraju was the President of Penumbra, a global healthcare company specializing in innovative therapies. His leadership at Penumbra focused on advancing the company's mission and expanding its global impact in the healthcare industry through innovative solutions and strategic initiatives.
Career at J.P. Morgan
Sri Kosaraju has an extensive background in finance, having served as the Head of Healthcare and co-Head of Technology Equity Capital Markets at J.P. Morgan. His tenure at J.P. Morgan involved leading significant financial operations and strategic capital market initiatives, which equipped him with a deep understanding of the healthcare and technology markets.